Presentation TVT 2022 Synchronous Type 3 EVAR Endoleaks Following Transfemoral Transcatheter Aortic Valve Replacement Presenter: Sankalp Patel June 08, 2022
Presentation TVT 2022 Approach to TAVR in Setting of a Complicated Left Atrial Thrombus in Transit Presenter: Rimmy Garg June 08, 2022
Presentation TVT 2022 Balloon Expandable TAVR for Severe Aortic Insufficiency: Device Anchoring by Pre-existent Mitral Annuloplasty Ring Presenter: Yashasvi Chugh June 08, 2022
Presentation TVT 2022 Sinus Sequestration After TAVR With Coronary Protection: Diagnosis and Management Presenter: Andrea Scotti June 08, 2022
News Conference News TVT 2021 New-Generation Watchman FLX Maintains Good Results Through 2 Years Todd Neale July 28, 2021
News Conference News TVT 2021 Optimizing Medical Therapy Before Clip Repair for MR? ‘This Is Hard’ Todd Neale July 27, 2021
News Conference News TVT 2021 Post-TAVI Pacemaker Rates Down in the US, but ‘Still Quite High’ Todd Neale July 23, 2021
News Conference News TVT 2021 Pascal Device Works Well for Tricuspid Regurgitation in Commercial Market Todd Neale July 22, 2021
Presentation TVT 2021 Three Cases of Challenging Anatomy for Left Atrial Appendage Closure Presenter: Sameer Gafoor July 22, 2021
News Conference News TVT 2021 Timing of Mitral Surgery After Failed TEER Influences Outcomes Todd Neale July 21, 2021
News Conference News TVT 2021 TAVI Outcomes Similar in Low-Risk Bicuspid, Tricuspid Aortic Stenosis at 1 Year Todd Neale July 20, 2021
News Conference News TVT 2020 Antithrombotics After PFO Closure: Much to Discuss, Little Data to Inform Yael L. Maxwell June 26, 2020
News Conference News TVT 2020 Stroke in TAVR: Full Impact of Embolic Devices, Anticoagulants, Technique Remain Unclear Todd Neale June 25, 2020
News Conference News TVT 2020 Device Explants After TAVR Rare but Risky Michael O'Riordan June 24, 2020
News Conference News TVT 2020 Real-world, Low-risk Patients Fare Well With Self-Expanding Evolut PRO Shelley Wood June 24, 2020
News Conference News TVT 2020 Reduced Leaflet Motion After TAVR: No Link to Impaired Hemodynamics, Events Michael O'Riordan June 23, 2020
News Conference News TVT 2020 Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years Michael O'Riordan June 22, 2020
Presentation TVT 2020 SAPIEN 3 Transcatheter Aortic Valve Replacement Compared with Surgery in Intermediate-risk Patients: A Propensity-Matched Analysis of 5-year Outcomes Presenter: Susheel K. Kodali June 21, 2020